|
|
Article: Targeted Genetics Strengthens Intellectual Property for AAV Vector Manufacturing.
- Article from:
- PR Newswire
- Article date:
- November 7, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE -- Targeted Genetics Corporation today announced the issuance of a patent covering additional approaches to manufacturing AAV (adeno-associated virus) vectors. The patent, U.S. #6,475,769 is titled "Methods and Cell Line Useful for Production of Recombinant Adeno-Associated Viruses" and covers the production of AAV vectors using stable cell lines. The patent was issued to the University of Pennsylvania and is exclusively licensed to Targeted Genetics.
Production of AAV vectors requires the introduction of several elements into a permissive cell -- the AAV vector and gene of interest, AAV rep and cap genes and a helper virus. Targeted Genetics has ...